Physician profile
Philip Simkovitz
NPI 1346358744
$23,942.67
in general payments reported to CMS, 2019-2025
46 companies · $3,579 in 2025
The $3,579 reported for 2025 was more than what 91% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,308 · 2020: $2,824 · 2021: $3,422 · 2022: $3,788 · 2023: $3,492 · 2024: $3,529 · 2025: $3,579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,177.39 |
| Education | $422.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $5,302.22 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $4,030.65 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,510.77 | 2019-2025 | Stiolto Respimat, Spiriva Respimat, Ofev |
| Mylan Specialty L.P. | $1,467.38 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $1,425.04 | 2019-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $1,265.68 | 2020-2025 | Acthar |
| Genentech USA, INC. | $1,172.28 | 2019-2025 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $1,164.19 | 2020-2025 | Glassia, Hyqvia, Cuvitru |
| Genzyme Corporation | $754.63 | 2019-2025 | |
| Amgen INC. | $590.07 | 2021-2024 | Tezspire |
| Novartis Pharmaceuticals Corporation | $472.51 | 2021-2025 | |
| Verona Pharma, INC. | $346.32 | 2025 | Ohtuvayre |
| Baxter Healthcare | $345.85 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $337.74 | 2019-2025 | Smartvest |
| Insmed, INC. | $277.94 | 2019-2025 | Arikayce |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Simkovitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.